Rotarix 58160-0740-21
Generic: Rotavirus Vaccine, Live, Oral
- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Vaccine
- Marketing Start
- February 1, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA125265
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Rotavirus A Type G1p(8) Strain Rix4414 Live Antigen | 1000 [CCID_50]/mL |
Drug Class
Actively Acquired Immunity [PE]Live Attenuated Rotavirus Vaccine [EPC]Rotavirus Vaccines [CS]
Selected Package
58160-0740-21Selected10 APPLICATOR in 1 CARTON (58160-740-21) / 1.5 mL in 1 APPLICATOR (58160-740-02)